TheNote.app
MarketWatch.com | Top Stories

Novo Nordisk’s stock tumbles as drugmaker lays out case for declining sales in 2026

The maker of Ozempic and Wegovy blamed pricing pressures and competition for its downbeat outlook.
favicon
marketwatch.com
marketwatch.com
Image for the article: Novo Nordisk’s stock tumbles as drugmaker lays out case for declining sales in 2026
RSS Hunter
Create attached notes ...